UW or FA?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

jfgavina

Full Member
10+ Year Member
Joined
Feb 16, 2011
Messages
555
Reaction score
25
Points
4,621
Location
Lisbon, Portugal
  1. Resident [Any Field]
Advertisement - Members don't see this ad
FA says that the main toxicity of L-dopa is arrhythmias, but when I got a question on the issue in UW they say that the main adverse effect is anxiety and agitation... And tachyarrhythmias was one of the options, so I picked it. Does L-dopa cause any kind of arrhythmia other than tachy as well as anxiety and agitation? even if it does I think FA should be corrected on this issue because it is very inespecific by only telling us that it causes arrhythmias.

who's got it right?

edit: they say "what effect is most likely to arise after adding carbidopa to a levodopa therapy?"

I hope someone can explain me this one!
 
Last edited:
I think the tachyarrythmia (d1 receptors - i'm assuming) is more an effect of PERIPHERAL conversion. But when you give carbidopa alongside levodopa you are eliminating all of the peripheral effects. I annotated the anx/agitation into my FA because that's a central effect, and you'd still get that if you prevented peripheral conversion with carbidopa.
 
I think the tachyarrythmia (d1 receptors - i'm assuming) is more an effect of PERIPHERAL conversion. But when you give carbidopa alongside levodopa you are eliminating all of the peripheral effects. I annotated the anx/agitation into my FA because that's a central effect, and you'd still get that if you prevented peripheral conversion with carbidopa.

this is correct. 👍
 
Top Bottom